ClinicalTrials HQ

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

Recruiting · NCT07203053 · Registry updated 2026-09-21
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2Extensive Stage Lung Small Cell CancerRecruitingPhase 22026-09-21NCT07203053

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Amgen180
ETOP IBCSG Partners Foundation17

19 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AO San Giovanni AddolorataRomaItaly1
CHU AngersAngersFrance87
Geneva University HospitalsGenevaSwitzerland8
Henry Dunant Hospital CenterAthensGreece3
HFR - Hôpital cantonalFribourgSwitzerland1
Hospital de la Santa Creu i Sant PauBarcelonaSpain64
Hospital General Universitario AlicanteAlicanteSpain3
Hospital Universitatrio Puerta del HierroMadridSpain1
Hospital Universitatrio Vall d'HebronBarcelonaSpain1
Hôpital Nord de MarseilleMarseilleFrance1
ICO Hospitalet H. Duran I Reynals / H. BellvitgeBarcelonaSpain1
Institut BergonieBordeauxFrance26
Instituto Europeo di Oncologia (IEO)MilanItaly3
Irccs IrstMeldolaItaly1
Istituto Nazionale Tumori "Regina Elena"RomaItaly3
Kantonsspital BadenBadenSwitzerland11
Kantonsspital St.GallenSankt GallenSwitzerland5
Lyon - Centre Léon BérardLyonFrance4
Santa Maria della Misericordia HospitalPerugiaItaly4